Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
HF Sinclair has added another 12% this week to close at $128.23, extending a rally that has now left the consensus analyst price target firmly in the rear-view mirror.
The stock's move to $128.23 puts it well above the Street mean target of $114. That gap has closed fast. The previous note flagged how quickly targets were being revised after the stock sat at $115.63 last Wednesday. Since then, Wells Fargo's Sam Margolin raised his target to $135 on Tuesday, and Barclays lifted to $122 on Monday, both maintaining Equal-Weight ratings. Goldman's Neil Mehta, who carries a Buy, raised to $142 last Thursday, the most bullish on the Street among those who have moved recently. The direction of travel is unanimous: every firm that acted this week raised rather than cut. But the stock is now trading above most of those freshly minted targets, which changes the shape of the conversation. Raymond James at $140 and Goldman at $142 remain the only targets still above where DINO trades. EPS momentum ranks in the 95th percentile over 30 days and the 94th percentile over 90 days, and the analyst recommendation differential scores at the 93rd percentile, reflecting how aggressively coverage has rotated positive in recent months. The PE is 8.4x and EV/EBITDA is around 5.7x, both reasonable for the refining sector, though the 30-day expansion in those multiples has been material as the stock re-rated.
The short-covering story accelerated this week and is directly connected to the price action. Short interest dropped 28% over the past seven days to 3.8% of the free float, an abrupt unwind from a position that was running close to 10 million shares as recently as last Thursday. That is a sharp and sudden exit: shorts who built positions through September are now retreating with the stock up nearly 19% in a month. The borrow market remains loose, with availability above 5,000%, meaning there is no technical squeeze dynamic at work here. Cost to borrow is still very low at 0.47%. The ORTEX short score has dropped to 35.8 from above 40 at the start of the month, a signal the model sees reduced short-side pressure. Covering drove the rally as much as any fundamental catalyst, and with the short base now materially smaller, that tailwind is largely spent.
Options positioning has shifted alongside the price move. The put/call ratio has drifted lower to 0.57, below its 20-day average of 0.58, and broadly flat versus recent weeks. The z-score is negligible at -0.09, meaning options traders are neither particularly bullish nor defensively positioned relative to the recent range. That reads as neutral, not complacent: the PCR 52-week range runs from 0.24 at the bullish extreme to 1.40 at the bearish extreme, and current readings are neither. Refining peers moved with DINO this week. MPC gained 10.3%, VLO added 8.9%, and PSX rose 8.5%, suggesting a sector-wide re-rating rather than a DINO-specific catalyst. The sector appears to be pricing in a more constructive crack-spread environment heading into year-end.
One structural story worth carrying forward is the activist position at REH Advisors. The firm filed a Schedule 13D amendment in August, trimming from 6.3% to 5.1% as it sold 2.375 million shares at $89.41, a price the stock has now well exceeded. REH remains on the register with an activist 13D designation, a fact that keeps a degree of corporate-governance optionality in play. As a reminder, 13D/G positions are as-last-disclosed around the 5% threshold, and REH could have moved below 5% without a further filing. Separately, ORTEX forecasts a 60% probability that a pending Lubricants and Specialties spinoff leads to a share-count decrease in both the Russell 3000 and Russell 1000, with dates currently estimated around end-2027. That is a long-dated structural event, not a near-term catalyst, but it frames the corporate strategy backdrop heading into the October 28 earnings call.
With the stock now above most analyst targets and the bulk of the short-covering move likely behind it, the October 28 print becomes the focal point: the question is whether management can deliver results that justify a valuation that has moved faster than even the most recently revised Street estimates.
See the live data behind this article on ORTEX.
Open DINO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
